Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global medical devices reimbursement market size is expected to reach USD 1028.2 billion by 2030, expanding at a CAGR of 8.8% from 2023 to 2030.
Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them.
For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted procedures were postponed.
However, during the pandemic recovery period, these surgeries are expected to improve particularly in Asia pacific as the countries such as Japan and China are actively involved in providing reimbursement to robotic-assisted providers to improve the accuracy of surgeries.
Such initiatives are likely to have a positive impact on market growth in the post-pandemic period. With an increasing demand for medical equipment, reimbursement services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, the increasing number of people pursuing insurance and consolidation of the healthcare system are major factors fueling the industry growth.
North America dominated the market with a revenue share of over 50.2% in 2022 and is expected to maintain its dominance over the forecast period. The rising demand for healthcare equipment and the increasing number of healthcare centers are expected to drive the industry in this region. The growing prevalence of chronic diseases is driving the demand for various healthcare instruments. This is further expected to support the growth of the regional market.
Over the years, the Centers for Medicare & Medicaid Services have reduced the reimbursement for diagnostic radiology in the U.S. For instance, in January 2022, a study published in Science Direct stated that, between 2011 - 2021, there was a steady decline in the reimbursement for diagnostic imaging studies. A continuation of this trend by the government agencies is expected to have a negative impact on the regional market growth in the post-pandemic period.
Companies Mentioned
- Unitedhealth Group
- Cigna
- Humana Inc.
- Allianz
- Aviva
- CVS Health
- WellCare Health Plans
- Nippon Life Insurance Company
- BNP Paribas
- Anthem Insurance Companies, Inc.
Medical Devices Reimbursement Market Report Highlights
- The private payer segment dominated the market with a revenue share of over 65.0% in 2022 due to the presence of a large number of private players
- By healthcare setting, the hospitals segment held the largest revenue share of over 51.8% in 2022 due to recent technological developments and high patient footfall requiring the use of healthcare instruments
- Asia Pacific is projected to witness rapid growth during the forecast period owing to the rising penetration of insurance services in rural and urban areas
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 275 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $501.8 Billion |
| Forecasted Market Value (USD) by 2030 | $1028.2 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Medical Device Reimbursement Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Medical Device Reimbursement Market Analysis Tools
Chapter 4. Medical Device Reimbursement: Payer Estimates & Trend Analysis
4.1. Medical Device Reimbursement Market: Key Takeaways
4.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Public
4.3.1. Public market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Private
4.4.1. Private market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Medical Device Reimbursement: Healthcare Setting Estimates & Trend Analysis
5.1. Medical Device Reimbursement Market: Key Takeaways
5.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Outpatient facilities
5.4.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Medical Device Reimbursement Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
For more information about this report visit https://www.researchandmarkets.com/r/l36qys
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
